Search by Drug Name or NDC
NDC 64764-0171-30 Dexilant 30 mg/1 Details
Dexilant 30 mg/1
Dexilant is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is DEXLANSOPRAZOLE.
MedlinePlus Drug Summary
Dexlansoprazole is used to treat the symptoms of gastroesophageal reflux disease (GERD; a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus [tube between the throat and stomach]) in adults and children 12 years of age and older. It is also used to treat esophagitis (swelling that may damage tissues of the esophagus) in adults and children 12 years of age and older. Dexlansoprazole is used for the maintenance treatment of esophagitis and healing in adults and children 12 years of age and older. Dexlansoprazole is in a class of medications called proton pump inhibitors. It works by decreasing the amount of acid made in the stomach.
Related Packages: 64764-0171-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dexlansoprazole
Product Information
| NDC | 64764-0171 |
|---|---|
| Product ID | 64764-171_c34971cf-0a79-428a-a456-20c48ee627e8 |
| Associated GPIs | 49270020006520 |
| GCN Sequence Number | 064793 |
| GCN Sequence Number Description | dexlansoprazole CAP DR BP 30 MG ORAL |
| HIC3 | D4J |
| HIC3 Description | PROTON-PUMP INHIBITORS |
| GCN | 16305 |
| HICL Sequence Number | 036085 |
| HICL Sequence Number Description | DEXLANSOPRAZOLE |
| Brand/Generic | Brand |
| Proprietary Name | Dexilant |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dexlansoprazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, DELAYED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | DEXLANSOPRAZOLE |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Pharmaceutical Class | Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022287 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64764-0171-30 (64764017130)
| NDC Package Code | 64764-171-30 |
|---|---|
| Billing NDC | 64764017130 |
| Package | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (64764-171-30) |
| Marketing Start Date | 2010-04-12 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 9.81915 |
| Pricing Unit | EA |
| Effective Date | 2023-06-21 |
| NDC Description | DEXILANT DR 30 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |